HOWEVER, DESPITE THE POTENTIAL BENEFITS, SOME PATIENTS STILL FEEL EMBARRASSED BY THEIR SKIN. MANY WILL CHOOSE TO COVER UP WITH MORE CLOTHING OR AVOID SOCIAL SITUATIONS ALTOGETHER.

BUT EVERYONE DESERVES TO HAVE FUN IN THE SUN. JOINING US NOW IS HEALTH CARE PROVIDER, MELINDA GREENFIELD, WITH HOW MODERATE-TO-SEVERE PLAQUE PSORIASIS PATIENTS CAN MAKE THE MOST OF WARM WEATHER.

BIO-Dr. Melinda Greenfield Bio

Dr. Melinda Greenfield is a Board Certified Dermatologist in private practice since 1999. She has offices in Ponte Vedra Beach, FL and Albany, GA and has an online Telehealth practice in nine states.

Dr. Greenfield attended The University of Maryland for her undergraduate degree and Nova Southeastern University for Medical School. She completed her internship at Sinai Hospital of Baltimore and her Dermatology residency at St. Barnabas Hospital in the Bronx, NY.

Dr. Greenfield is past president of the Dougherty County Medical Society, the Georgia Osteopathic Medical society and previously served on the Editorial Board of the Journal of the American Osteopathic College of Dermatology.

Dr. Greenfield is a clinical assistant professor at The Georgia Campus of the Philadelphia College of Osteopathic Medicine, The Medical College of Georgia, PCOM South Georgia and The Orlando College of Osteopathic Medicine. She teaches the second-year dermatology curriculum to medical students and has students and residents rotate in her office throughout the year.

Dr. Greenfield has lectured at multiple meetings throughout the years and has authored four publications. She participated in an episode of The Balancing Act on Lifetime TV that highlighted psoriasis and is on the Speaker Board for several pharmaceutical companies.

In her free time, Dr. Greenfield enjoys bike riding, working out in the gym, gardening, cooking and spending time with her family.

IMPORTANT SAFETY INFORMATION

What is the most important information I should know about ILUMYA^® (tildrakizumab-asmn)?

Do not use ILUMYA if you have had a severe allergic reaction to ILUMYA or any of its ingredients.

Get emergency medical help right away if you get any of the following symptoms of a serious allergic reaction:

• feel faint
• trouble breathing or throat tightness
• swelling of your face, eyelids, lips, mouth, tongue or throat
• chest tightness
• skin rash

What is ILUMYA?

ILUMYA is a prescription medicine used to treat adults with moderate to severe plaque psoriasis who may benefit from taking injections, pills (systemic therapy), or phototherapy (treatment using ultraviolet or UV light).

IMPORTANT SAFETY INFORMATION (continued)

ILUMYA is a medicine that may lower the ability of your immune system to fight infections and may increase your risk of infections. Your healthcare provider should check you for infections and tuberculosis (TB) before starting treatment with ILUMYA and may treat you for TB before you begin treatment with ILUMYA if you have a history of TB or have active TB. Your healthcare provider should watch you closely for signs and symptoms of TB during and after treatment with ILUMYA.

Tell your healthcare provider right away if you have an infection or have symptoms of an infection, including:

• fever, sweats, or chills
• muscle aches
• weight loss
• cough
• warm, red, or painful skin or sores on your body different from your psoriasis
• diarrhea or stomach pain
• shortness of breath
• burning when you urinate or urinating more often than normal
• blood in your phlegm (mucus)

Before receiving ILUMYA, tell your healthcare provider about all of your medical conditions, including if you:

• have any of the conditions or symptoms listed in the section “What is the most important information I should know about ILUMYA?”
• have an infection that does not go away or that keeps coming back
• have TB or have been in close contact with someone with TB
• recently received or are scheduled to receive a vaccine (immunization). You should avoid receiving live vaccines during treatment with ILUMYA.
• are pregnant or plan to become pregnant. It is not known if ILUMYA can harm your unborn baby.
• are breastfeeding or plan to breastfeed. It is not known if ILUMYA passes into your breast milk.

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.

It is not known if ILUMYA is safe and effective in children under 18 years of age.

What are the possible side effects of ILUMYA?

ILUMYA may cause serious side effects. See “What is the most important information I should know about ILUMYA?”

The most common side effects of ILUMYA include: upper respiratory infections, injection site reactions and diarrhea. These are not all of the possible side effects of ILUMYA. Call your doctor for medical advice about side effects.

You are encouraged to report any negative side effects of ILUMYA to FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088. You are also encouraged to report side effects or ADEs (adverse drug events) to our Drug Safety Department at 1-800-406-7984 or drug.safetyUSA@sunpharma.com (preferred) with as much information as available.

Please read the full Prescribing Information and Medication Guide for ILUMYA and discuss any questions with your doctor.

#warmerweather #psoriasis #tips #skin #plaque #symptoms #sunlight #embarrassed #drmelindagreenfield #patients #healthcare #medical #sinaihospital #ilumya #tildrakizumab-asmn

The post IT’S MORE THAN SKIN DEEP How Warmer Weather Affects Psoriasis & Tips to Help Those Impacted appeared first on Good News!.

There is now a new treatment option for the estimated 2 million people in the United States living with moderate-to-severe plaque psoriasis1,2,3 whose symptoms may make day-to-day life more challenging. For those that aren’t familiar with psoriasis, it is a widely prevalent, chronic, systemic immune-mediated disease.4

And up to 90% of patients with psoriasis have psoriasis vulgaris, also known as plaque psoriasis,5 which is characterized by distinct round or oval plaques typically covered by silvery-white scales.

One of the challenges that both doctors and patients face is that despite the availability of therapies, many people living with plaque psoriasis in the United States are untreated or undertreated.5,6

But good news has arrived. The U.S. Food and Drug Administration (FDA) has officially approved a new treatment for adults with moderate-to-severe plaque psoriasis who are candidates for systemic therapy or phototherapy.

Dr. April Armstrong, dermatologist and clinical investigator in one of the treatment’s trials and Associate Dean and Professor of Dermatology at the University of Southern California, alongside Leah M. Howard, J.D., President and CEO of the National Psoriasis Foundation, will discuss the impact of psoriasis and a new, FDA-approved oral treatment for moderate-to-severe plaque psoriasis. *

*Dr. April Armstrong and Leah Howard are paid spokespeople and are being compensated for their time.

Interview is courtesy: Bristol Myers Squibb

1. Armstrong AW, Mehta MD, Schupp CW, Gondo GC, Bell SJ, Griffiths CEM. Psoriasis prevalence in adults in the United States. JAMA Dermatol.2021;157(8):940-946. doi:10.1001/jamadermatol.2021.2007

2 Armstrong AW, Read C. Pathophysiology, clinical presentation, and treatment of psoriasis: a review. JAMA. 2020;323(19):1945-1960. doi:10.1001/jama.2020.4006

3 Armstrong et al. Undertreatment, Treatment Trends, and Treatment Dissatisfaction Among Patients With Psoriasis and Psoriatic Arthritis in the United States: Findings From the National Psoriasis Foundation Surveys, 2003-2011. JAMA Dermatol. 2013;149(10):1180–1185.
4. Armstrong AW, Schupp C, Wu J, Bebo B. Quality of life and work productivity impairment among psoriasis patients: findings from the National Psoriasis Foundation survey data 2003–2011. PloS One. 2012;7(12):e52935.

5. Menter A, Gottlieb A, Feldman SR, Van Voorhees AS et al. Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 1. Overview of psoriasis and guidelines of care for the treatment of psoriasis with biologics. J Am Acad Dermatol. 2008 May;58(5):826-50.

6. Lebwohl M, Langley RG, Paul C, et al. Evolution of patient perceptions of psoriatic disease: results from the Understanding Psoriatic Disease Leveraging Insights for Treatment (UPLIFT) survey. Dermatol Ther (Heidelb). 2022;12(1):61-78. doi:10.1007/s13555-021-00635-4

#aprilarmstrong #leahhoward #plaquepsoriasis #psoriasis #treatment #immunedisease #prevalent #chronic #systemicdisease #clinicaltreatment

The post PEOPLE WITH THE SKIN CONDITION KNOWN AS MODERATE-TO-SEVERE PLAQUE PSORIASIS NOW HAVE A NEW Rx TREATMENT OPTION appeared first on Good News!.

For the millions of people living with psoriasis, like Gloria, the impact on their daily lives extends far beyond the physical symptoms. Among some of the many grievances Gloria can share about her last 10 years living with the condition are:

Strangers commenting on her skin when she’s out in public

Leaving bits of skin on furniture — and even needing to vacuum her bedsheets

Wearing her hair down during the unbearably hot Texas summer to avoid showing affected areas on the back of her neck

Times when people haven’t wanted to touch her skin, such as a cashier not wanting to take a $20 bill from her hands, during a flare-up

Although Gloria tried a number of treatments to help improve her psoriasis, many of these treatments didn’t give her the results she was looking for — as is often the case among psoriasis patients.

Fortunately, there’s hope. A new, innovative treatment in plaque psoriasis is getting high praise from people like Gloria, as well as the medical community. Following more than 25 years of minimal innovation in the topical psoriasis treatment space, the FDA recently approved a steroid-free, prescription cream for plaque psoriasis in adults — the first in its class in the U.S.

Linda Stein-Gold, MD, Director of Dermatology Clinical Research at Henry Ford Health System and Gloria as they discuss the significant impact plaque psoriasis may have on a person’s life and what this new treatment may mean for those who are suffering with plaque psoriasis as well.

Interview is courtesy: Dermavant Sciences

#plaquepsoriasis #psoriasis #advocate #chronicinflammatorydisease #patchesofskin #itchy #painful #disfiguring #gloria #physicalsymptoms #drlindastein-gold #health #clinical #dermavantsciences

The post The Truth About Living with Plaque Psoriasis And How to Become Your Own Advocate appeared first on Good News!.